Evidence map›Paper›PMID 40910237›Full record

ArticleCurrent medicinal chemistry2026

Diagnosis and Potential Therapy of Brain Diseases Using

Yumei An, Xinqi Huang, Mingyuan Xu, Xianzhe Li, Haiyan Shan, Mingyang Zhang

Abstract readScoping Review
PubMed Publisher
In one paragraph

Article in Current medicinal chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Pharmaceuticals (Basel, Switzerland) · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yumei AnShanghai Key Lab of Forensic Medicine, Key Lab of Forensic Science, Ministry of Justice, China (Academy of Forensic Science), Shanghai, 200063, China.
Xinqi HuangThe Affiliated Guangji Hospital, School of Basic Medicine, Suzhou Medical College of Soochow University, Suzhou, 215123, Jiangsu, China.
Mingyuan XuThe Affiliated Guangji Hospital, School of Basic Medicine, Suzhou Medical College of Soochow University, Suzhou, 215123, Jiangsu, China.
Xianzhe LiThe Affiliated Guangji Hospital, School of Basic Medicine, Suzhou Medical College of Soochow University, Suzhou, 215123, Jiangsu, China.
Haiyan ShanDepartment of Obstetrics and Gynecology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China.
Mingyang ZhangShanghai Key Lab of Forensic Medicine, Key Lab of Forensic Science, Ministry of Justice, China (Academy of Forensic Science), Shanghai, 200063, China.ORCID 0000-0001-7084-6237

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThis paper provides a comprehensive review examining the application of copper radionuclides, particularly

methodsTwo researchers conducted an independent search of the PubMed and Web of Science databases for original research articles published in English. Following a screening process based on titles and abstracts, 42 publications reporting the use of copper radionuclides for diagnosing or treating brain diseases were selected for this review.

resultsThe analysis revealed that several copper isotopes, namely 60 Cu, 61 Cu, 62 Cu, DISCUSSION:

conclusion

Indexed as

Brain DiseasesCopper RadioisotopesRadiopharmaceuticalsAlzheimer DiseaseAnimalsBrain Injuries, TraumaticBrain NeoplasmsHepatolenticular DegenerationHumansCopper-64Copper RadioisotopesRadiopharmaceuticalsbrain diseasemenkes diseaseParkinson's diseasradiopharmaceuticalradiotherapy<sup>64</sup>Cu radionuclide

Identifiers

PMID40910237

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.